Trovagene, Inc. (TROV)

Oncology Corporate Profile

Stock Performance

0.0000
0.0000

3 Month Stock History Chart

HQ Location

11055 Flintkote Avenue
San Diego, CA 92121

Company Description

Trovagene is a precision medicine biotechnology company developing oncology therapeutics for improved cancer care by leveraging its proprietary Precision Cancer Monitoring® (PCM) technology in tumor genomics. Trovagene has broad intellectual property and proprietary technology to measure circulating tumor DNA (ctDNA) in urine and blood to identify and quantify clinically actionable markers for predicting response to cancer therapies. Trovagene offers its PCM technology at its CLIA/CAP – accredited laboratory and plans to continue to vertically integrate its PCM technology with precision cancer therapeutics.

Website: https://www.trovagene.com/

This company does not have any commercial products
  • Brand
  • Generic
  • Investigational
Brand / Product Class Area of Study Phase Partnership
PCM-075PLK1 inhibitorAcute Myelogenous Leukemia (AML)I
PCM-075 (+ decitabine)PLK1 inhibitorAcute Myelogenous Leukemia (AML)I
PCM-075PLK1 inhibitorVarious cancer typesI

View additional information on product candidates here »

Source: https://www.trovagene.com/

Recent News Headlines

There are no news items to display